ArticleCurrent oncology (Toronto, Ont.)2009

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement.

P M Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.